Ovoca Bio plc
OVB.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | £401 | £1 | £4 | £14 |
| - Cash | £3 | £3 | £4 | £7 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | £398 | -£3 | £1 | £7 |
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | – | – | – | – |
| Gross Profit | £0 | £0 | £0 | £0 |
| % Margin | – | – | – | – |
| EBITDA | £0 | -£1 | -£3 | -£6 |
| % Margin | – | – | – | – |
| Net Income | -£1 | -£5 | -£6 | -£5 |
| % Margin | – | – | – | – |
| EPS Diluted | 0 | -0.063 | -0.069 | -0.067 |
| % Growth | 100% | 9% | -2.5% | – |
| Operating Cash Flow | -£1 | £1 | -£5 | -£4 |
| Capital Expenditures | £0 | -£0 | -£0 | -£0 |
| Free Cash Flow | -£1 | £1 | -£5 | -£5 |